SignatureFD’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

SignatureFD’s Portfolio RXDX Stock Details RXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1	Closed	-$107	–	3408
2023 Q1	$107	Sell	1 -10	-91%	-$1.15K	﹤0.01%	3237
2022 Q4	$1.21K	Buy	+11	New	+$713	﹤0.01%	2933

Other funds holding RXDX

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

FCA

FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

SignatureFD's RXDX Position: Q2 2023 in Review

SignatureFD sold out of Prometheus Biosciences, Inc. Common Stock (RXDX) in Q2 2023, closing a stake of 1 share — an estimated $107 sold.

SignatureFD first reported a position in RXDX in Q4 2022 and held it in 2 quarters. The position peaked at $1.21K in Q4 2022. 2 funds tracked by Wall St. Rank hold RXDX as of Q2 2023.

SignatureFD reported no remaining Prometheus Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
SignatureFD sold 1 Prometheus Biosciences, Inc. Common Stock share in Q2 2023, an estimated $107.
SignatureFD first reported a position in Prometheus Biosciences, Inc. Common Stock in Q4 2022 and held it in 2 quarters.
SignatureFD's Prometheus Biosciences, Inc. Common Stock position peaked at $1.21K in Q4 2022.
2 funds tracked by Wall St. Rank held Prometheus Biosciences, Inc. Common Stock as of Q2 2023.

Based on SignatureFD's 13F filing for Q2 2023, filed 1 Aug 2023.